Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Mastocytosis, Systemic × Dasatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myeloid, Acute 2 Leukemia 2 Relapsed Pediatric Solid Tumor 1 Mastocytosis, Systemic 1 Lymphoma, T-Cell, Peripheral 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Gastrointestinal Stromal Tumors 1 Diffuse Intrinsic Pontine Glioma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

midostaurin 1 masitinib 1 Phlebotomy 1 Dasatinib 1 Cladribine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00979160 2009-09-18

Evaluation of Response of Dasatinib to Treat Mastocytosis

Federico II University

Phase 2 Unknown

Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡